Location History:
- Plaza de la Revolución, Ciudad de la Habana, CU (2008)
- C. Habana, CU (2008)
- Ciudad de La Habana, CU (2012 - 2014)
- La Habana, CU (2016)
- Havana, CU (2022 - 2023)
Company Filing History:
5 out of 70 
1 out of 2 
1 out of 1 Years Active: 2008-2023
Title: Innovations of Gerardo Enrique Guillén Nieto
Introduction
Gerardo Enrique Guillén Nieto is an accomplished inventor based in Havana, Cuba. With a total of 8 patents to his name, he is recognized for his significant contributions to the fields of pharmaceuticals and biotechnology. His innovative work focuses on the development of compositions and medicaments aimed at addressing critical health issues such as hepatitis B and cardiac conditions.
Latest Patents
Among his notable inventions is a **pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis B virus**. This invention presents a composition that combines the surface antigen (HBsAg) of the hepatitis B virus (HBV) and the nucleocapsid antigen (HBcAg). Importantly, this composition incorporates messenger ribonucleic acid (mRNA), which constitutes over 45% of the total ribonucleic acid (RNA) in the HBcAg. This pioneering work serves as a preventative or therapeutic measure against chronic hepatitis B and can also enhance immune responses when administered alongside other antigens.
Another remarkable invention from Gerardo is the **use of GHRP-6 as a late cardioprotective and cardiac restoration medicament**. This development relates to the use of the growth hormone releasing peptide-6 (GHRP-6) in formulating a medicament that aids in cardiac protection and restoration. The medicament is designed to treat conditions associated with low cardiac output, allowing for therapeutic intervention even days after the myocardium has experienced adverse events such as stunning or ischemia.
Career Highlights
Gerardo has made substantial contributions while working at esteemed institutions, notably **Centro de Ingeniería Genética y Biotecnología**. His dedication to advancing biotechnology and pharmaceuticals is reflected in his research and innovative inventions.
Collaborations
Throughout his career, Gerardo has collaborated with distinguished professionals, including **Julio César Aguilar Rubido** and **Eduardo Pentón Arias**. These partnerships have been vital in enhancing the scope and impact of his research endeavors.
Conclusion
Gerardo Enrique Guillén Nieto exemplifies the spirit of innovation through his groundbreaking work in pharmaceuticals and biotech. His contributions have the potential to greatly improve health outcomes, particularly in the treatment of hepatitis B and cardiac conditions, solidifying his status as a prominent inventor in his field.